US HB3391 | 2017-2018 | 115th Congress
Status
Sponsorship: Slight Partisan Bill (Republican 6-3)
Status: Introduced on July 25 2017 - 25% progression, died in committee
Action: 2017-09-06 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Pending: House Subcommittee on Crime, Terrorism, Homeland Security, And Investigations Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 25 2017 - 25% progression, died in committee
Action: 2017-09-06 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Pending: House Subcommittee on Crime, Terrorism, Homeland Security, And Investigations Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Medical Marijuana Research Act of 2017 This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research with marijuana for medical purposes. The Drug Enforcement Administration must register: (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research. The Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and offer to sell immature plants and seeds to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.
Title
Medical Marijuana Research Act of 2017
Sponsors
| Rep. Andy Harris [R-MD] | Rep. Earl Blumenauer [D-OR] | Rep. Morgan Griffith [R-VA] | Rep. Zoe Lofgren [D-CA] |
| Rep. Eleanor Norton [D-DC] | Rep. Carlos Curbelo [R-FL] | Rep. Mark Amodei [R-NV] | Rep. David Roe [R-TN] |
| Rep. Brett Guthrie [R-KY] |
History
| Date | Chamber | Action |
|---|---|---|
| 2017-09-06 | House | Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. |
| 2017-07-28 | House | Referred to the Subcommittee on Health. |
| 2017-07-25 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2017-07-25 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2017-07-25 | House | Introduced in House |
Same As/Similar To
SB780 (Related) 2017-03-30 - Read twice and referred to the Committee on Finance.
HB1824 (Related) 2017-04-24 - Referred to the Subcommittee on Immigration and Border Security.
HB1824 (Related) 2017-04-24 - Referred to the Subcommittee on Immigration and Border Security.
Subjects
Administrative law and regulatory procedures
Alternative treatments
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Food and Drug Administration (FDA)
Health
Health personnel
Licensing and registrations
Medical research
Research administration and funding
Alternative treatments
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Food and Drug Administration (FDA)
Health
Health personnel
Licensing and registrations
Medical research
Research administration and funding
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/115th-congress/house-bill/3391/all-info |
| Text | https://www.congress.gov/115/bills/hr3391/BILLS-115hr3391ih.pdf |
